Prolactinomas

• CLINICAL_TRIALS trial_result · 2020-01-13
  Clinical Trial Update: Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy [Phase 2]

  Phase 2 trial updating targeted therapy with lapatinib in recurrent pituitary tumors resistant to standard therapy has completed with result…

• CLINICAL_TRIALS trial_result · 2016-06-16
  Clinical Trial Update: Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas [Phase 2, Phase 3]

  Phase 2/3 clinical trial update reporting results for the combination of cabergoline and pasireotide in non-functioning pituitary adenomas a…